Where does it come from?
News
Contrary to popular belief, Lorem Ipsum is not simply random text. It has roots in a piece of classical Latin literature from 45 BC, making it over 2000 years ... Read more
What is Lorem Ipsum?
News
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took ... Read more
Where does it come from?
News
Contrary to popular belief, Lorem Ipsum is not simply random text. It has roots in a piece of classical Latin literature from 45 BC, making it over 2000 years ... Read more
What is Lorem Ipsum?
News
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took ... Read more
Rare Disease Film Festival Highlights Patient and Researcher Unity
cystic fibrosis, News
Rare disease-themed videos glowed on a large screen before an audience of people in wheelchairs, with crutches, and bearing oxygen tanks this Nov. 9 and 10 in San Francisco. ... Read more
Neurological Disease Expert Joins MDA’s Research Team
Read moreThe Muscular Dystrophy Association (MDA) has recently added to its research team an expert in neurological diseases in order to enhance and improve its healthcare service programs. MDA has hired Lianna R. Orlando, Scientific Program Officer who comes to MDA from Fidelity Biosciences Research Initiative. There at Fidelity, she was the Associate Director and she oversaw the […]
University of Helsinki Researchers Discover Vitamin B3 Form that is Effective in Attenuating Mitochondrial Myopathy Progression
Researchers from the University of Helsinki recently found that a vitamin B3 form might be effective in attenuating the progression of mitochondrial myopathy. The study is published in the ... Read more
Enlarged Prostate Therapy Fexapotide Actually Improves Patients’ Sexual Function, Studies Show
News
Fexapotide triflutate improves the sexual functioning of men with an enlarged prostate, according to combined results of four Phase 3 clinical trials. The therapy’s developer, Nymox Pharmaceutical, had previously reported that ... Read more
Naftopidil Seen To Lower Blood Pressure in BPH Patients With Hypertension, Korean Study Finds
News
Naftopidil, a medication used to treat benign prostatic hyperplasia (BPH) outside the United States, lowers blood pressure in BPH men with hypertension while having no effect on those with ... Read more
Αlpha Blocker Isn’t Necessary in LUTS Patients Using 5ARIs, But Switch May Need Care, Study Suggests
News
Patients being treated with a combination 5-alpha reductase inhibitor (5ARIs) and an alpha blocker may switch to 5ARIs alone with no worsening of lower urinary tract symptoms (LUTS), a new ... Read more